These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 6451267
1. [Modulation of macrophage-mediated toxicity to cancer cells in vitro by liposomes and endotoxins]. Olsson NO, Jeannin JF, Martin F. C R Seances Soc Biol Fil; 1980; 174(6):1067-71. PubMed ID: 6451267 [Abstract] [Full Text] [Related]
8. Cytotoxic activity of lymphocytes. V. Role of soluble toxin in macrophage-inhibited cultures of tumor cells. Reed WP, Lucas ZJ. J Immunol; 1975 Aug; 115(2):395-404. PubMed ID: 1097513 [Abstract] [Full Text] [Related]
9. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators. Fogler WE, Talmadge JE, Fidler IJ. J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360 [Abstract] [Full Text] [Related]
16. Differences in the tumoricidal activation of rat and mouse macrophages by endotoxins. Jeannin JF, Lagadec P, Reisser D, Martin F. Exp Cell Biol; 1985 Sep; 53(5):270-80. PubMed ID: 2931311 [Abstract] [Full Text] [Related]
17. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines. Sone S, Poste G, Fidler IJ. J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253 [Abstract] [Full Text] [Related]
19. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy. Han X, Wilbanks GD, Devaja O, Ruperelia V, Raju KS. Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372 [Abstract] [Full Text] [Related]